Subscribe to our latest updates, reports and upcoming events. Subscribe >
De Para
Subscribe to our latest updates, reports and events.
SubscribeShowing 1 - 10 of 74
Ordenar por
Article 21 jan 2021
Despite welcome news of several viable vaccines in production, having been approved for emergency use globally, the race to develop protections against and treatments for COVID-19 is far from over. Alongside the approved vaccines, there are more than 250 potential vaccines at various stages of development. These vaccines will require worldwide roll out in order to contain and protect against the continued spread of COVID-19.
Report 12 jan 2021
Advances in genomics are turbocharging the global response to the COVID-19 pandemic and continuing to redefine how we understand healthcare.
Article 5 jan 2021
In early December 2020, the UK government announced with considerable fanfare its approval of Pfizer/BioNTech’s COVID-19 vaccine. Around 40 million doses were ordered, and the UK’s mass vaccination programme commenced in December 2020, with the US, Canada, Bahrain and Saudi Arabia close behind. On 30 December 2020, the Oxford AstraZeneca vaccine received UK approval with the first doses administered in early January.
Article 21 dez 2020
Almost one year on from the first reported case of the novel coronavirus in the Wuhan province of China, pensioner Margaret Keenan and intensive care unit nurse Sandra Lindsay, have now received the first vaccines in the UK and US respectively.
Report 27 nov 2020
Integrating new technology systems into large institutions is notoriously difficult even when it is carefully planned. So how has the rapid roll-out of telehealth during the pandemic altered the risk landscape?
Article 23 nov 2020
In this Q&A, Jenny Yu, the Industry Practice Leader for Chemicals and Life Sciences in the UK at Marsh & McLennan shares her thoughts on the impact of COVID-19 on the life sciences sector.
Article 3 nov 2020
We attended a variety of virtual sessions over four days of ACRM 2020, including seminars, panel debates and product exhibitions from a diverse range of institutions, clinicians and entrepreneurs.
Article 28 out 2020
This year’s American Congress of Rehabilitation Medicine annual conference was itself an example of technological improvisation, with virtual delegates attending online due to the pandemic. One of the recurring themes of its numerous seminars was the medical necessity for reinvention of traditional rehabilitation models and the involuntary shift of providers towards caretech solutions for reasons of business continuity and infection control.
Article 27 out 2020
Opioid addiction has received growing publicity in the US in recent years, with hundreds of thousands affected. Despite regulatory changes the problem remains significant, to the extent that the issue has featured in the 2020 race for the White House.
Article 26 out 2020
The American Congress of Rehabilitation Medicine 2020 annual conference featured several limb loss or amputation-focused presentations. Many of these highlighted a new approach that is developing in the US, where the sector as a whole collaborates on accessible platforms with the aim of sharing information and resources so as to improve treatment and quality of life for amputees.
